The relationship between myasthenia gravis and COVID-19: a systematic review
- PMID: 35818475
- PMCID: PMC9261189
- DOI: 10.1186/s41983-022-00516-3
The relationship between myasthenia gravis and COVID-19: a systematic review
Abstract
Introduction: Viral infection such as coronavirus disease 2019 (COVID-19) can exacerbate and aggravate neurological disorders due to autoimmune etiology like myasthenia gravis (MG). Experimental therapies used in COVID-19 are also factors that can cause the worsening of MG symptoms. This review aimed to assess and conclude the research-based study systematically to analyze the relationship of MG and COVID-19.
Method: This study was conducted in accordance to Cochrane handbook for systematic reviews and the guideline of preferred reporting items for systematic review and meta-analysis (PRISMA) and synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. Inclusion criteria in this review were primary studies of every design, articles published in English around January 2000-October 2021, and the study used human as subject. A systematic literature finding was applied in 15 electronic scientific resources. The authors evaluated the study quality and risk of bias of each retrieved article.
Results: The authors found the study through electronic scientific resources that met inclusion and exclusion criteria. The authors evaluated 362 articles identified in literature searching, 22 articles met the criteria for this review and then underwent the evaluation of study quality and risk of bias.
Conclusion: COVID-19 infection can increase the risk of new-onset MG, myasthenic crisis, respiratory failure, and mortality rate due to cytokine storm in MG patients. The management of COVID-19 patients with MG is tailored to each person and based on national guidelines and local expert recommendations.
Keywords: Autoimmune; COVID-19; Myasthenia gravis; Neurology.
© The Author(s) 2022.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests/conflicts of interest concerning this article.
Similar articles
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Therapeutic Plasma Exchange in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis of Comparative Evidence.Front Neurol. 2021 Aug 31;12:662856. doi: 10.3389/fneur.2021.662856. eCollection 2021. Front Neurol. 2021. PMID: 34531809 Free PMC article.
-
Evidence-Based Practice in Rehabilitation of Myasthenia Gravis. A Systematic Review of the Literature.J Funct Morphol Kinesiol. 2020 Sep 27;5(4):71. doi: 10.3390/jfmk5040071. J Funct Morphol Kinesiol. 2020. PMID: 33467286 Free PMC article. Review.
-
Myasthenia gravis in pregnancy: Systematic review and case series.Obstet Med. 2022 Jun;15(2):108-117. doi: 10.1177/1753495X211041899. Epub 2022 Jan 10. Obstet Med. 2022. PMID: 35845224 Free PMC article.
Cited by
-
The Incidence of Myasthenia Gravis in the Province of Ferrara, Italy, in the Period of 2008-2022: An Update on a 40-Year Observation and the Influence of the COVID-19 Pandemic.J Clin Med. 2023 Dec 30;13(1):236. doi: 10.3390/jcm13010236. J Clin Med. 2023. PMID: 38202243 Free PMC article.
-
COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.Brain Behav. 2022 Dec;12(12):e2789. doi: 10.1002/brb3.2789. Epub 2022 Oct 28. Brain Behav. 2022. PMID: 36306401 Free PMC article. Review.
-
Muscle weakness post-COVID: a practical guide for primary care.Br J Gen Pract. 2024 Nov 28;74(749):573-575. doi: 10.3399/bjgp24X740229. Print 2024 Dec. Br J Gen Pract. 2024. PMID: 39609044 Free PMC article. No abstract available.
-
Complications of Long COVID: Unraveling a Case of Very-Late-Onset Myasthenia Gravis.Cureus. 2024 Sep 30;16(9):e70552. doi: 10.7759/cureus.70552. eCollection 2024 Sep. Cureus. 2024. PMID: 39479090 Free PMC article.
-
Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics.J Transl Med. 2023 Aug 24;21(1):564. doi: 10.1186/s12967-023-04421-y. J Transl Med. 2023. PMID: 37620910 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous